Report

Pharmaceutical Industry 2H2023 - POLICY ENVIRONMENT SUPPORTS GROWTH

In 2022, the ETC channel suffered a prolonged shortage of drugs. It has prompted the administration to solve problems with the development of the ETC channel both in the medium and long term. In 1H2023, many new policy documents were issued that brought the ETC channel back strongly. On the other hand, the OTC channel has shown signs of deceleration with the increase in the ETC market share, and the COVID-19 epidemic has passed. We believe that DBD and IPM will continue to benefit in 2H2023 thanks to the focus on the ETC channel.

Provider
Viet Dragon Securities
Viet Dragon Securities

Viet Dragon Securities belongs to top 20 biggest securities companies in terms of chartered capital in Vietnam. With a qualified, dedicated and professional team, a widespread network, advanced technology, diversified products and services, and good relationship with local and foreign institutions, we provide a wide range of services and products to our clients both individuals and institutions, both local and foreign. We commit to provide our clients with promising investment opportunities and a comprehensive and professional financial investment services.

RongViet Research reports are diversified and abundant, along with in-depth analysis and performed by experienced, highly-qualified and knowledgeable teams. With the objectives of transparency, accurate and timely manner, RongViet believes that our products would always be important sources of information for customers/investors’ investment decisions.

Analysts
Quan Cao

Other Reports from Viet Dragon Securities

ResearchPool Subscriptions

Get the most out of your insights

Get in touch